Connection

Ki Chung to Proto-Oncogene Proteins c-mdm2

Back to Details
This is a "connection" page, showing publications Ki Chung has written about Proto-Oncogene Proteins c-mdm2.
Ki Chung
Connection Strength
0.047
Proto-Oncogene Proteins c-mdm2
  1. Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53. Clin Cancer Res. 2021 10 01; 27(19):5236-5247.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.